Home > News > As the drug market moves to injectables, biotech majors strive to develop targeted-injection drugs for the treatment of a host of disorders
April 29th, 2007
Abstract:
Indian biotech majors, however, seem steady on their path. Dabur Pharma, for instance, achieved a breakthrough with its Nanoxel—a drug delivery system for the widely used anti-cancer drug Paclitaxel. This nanoscale drug delivery system is India's first indigenously developed nanotechnology-based chemotherapy agent, and also the first outside of the US. Positioned as a safer therapy for advanced breast, non-small-cell lung, and ovarian cancers, it enables therapy to take a preferential course to the cancerous cells and directly interact with the tumour-causing agents thereby throwing open a larger window for anti-tumour activity. It also ensures that the patient receives the full measure of therapy while limiting the adverse side effects and toxicity affected by the drug. This would be a great advantage because the biggest challenge faced in cancer therapy is the incidence of severe side effects that the cancer patient has to encounter while undergoing chemotherapy.
Source:
financialexpress.com
Related News Press |
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Simulating magnetization in a Heisenberg quantum spin chain April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||